Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tracking Patient Manifestations of Behçet’s Syndrome around the World

Yusuf Yazici, MD  |  Issue: July 2010  |  July 1, 2010

Pathogenesis of Behçet’s Syndrome

Although vascular injury is quite common in BS and can involve venous and arterial vessels of all sizes, frank necrotizing vasculitis of the small and medium-sized arteries as seen in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides is infrequent in patients with BS. Similarly infrequent are giant cells and immune complex–type cutaneous venulitis. These “negative” findings make the vascular involvement in BS unique. Furthermore, there is little evidence for vasculitis in some common lesions of BS. For example, there is no evidence for vascular injury in the papulopustular lesions of the skin and scanty evidence for a frank vasculitis in the CNS lesions. Conversely, the diffuse inflammatory disease in all layers of the large veins characteristically involving substantial segments of the vessel wall, the pulmonary artery aneurysms specific to this condition, and pseudoaneurysms of the large arteries (most probably secondary to vasculitis of the vasa vasorum) are unique findings.

The genetics of BS are, at present, uncertain. No clear Mendelian pattern has emerged. In endemic areas, approximately one in 10 families have more than one family member who is affected. The most consistent genetic association has been with HLA-B51, which explains only approximately 20% of the disease heritability.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It is currently popular to group BS with autoinflammatory disorders. This categorization is debatable given that most autoinflammatory conditions (with familial Mediterranean fever being a good example) are monogenic and predominantly pediatric conditions.

Recently, it has been noted that there may be some clustering in disease expression in BS. Through a series of mainly clinical observations, two clusters have been defined. The first is the cluster of superficial vein thrombosis, deep vein thrombosis, and dural sinus thrombi; the second cluster is that of acne, arthritis, and enthesitis.4 The association of acne with arthritis and the recent observation of the pustule lesions of BS being nonsterile brings into discussion a reactive arthritis type of disease mechanism, at least for this disease cluster.5 The presence of such clusters may suggest there is more than one disease mechanism involved in this complex disorder.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There are no specific laboratory findings in BS. The erythrocyte sedimentation rate and C-reactive protein level are usually moderately elevated, but these do not correlate well with disease activity. Autoantibodies such as rheumatoid factor, antinuclear antibodies, anticardiolipin antibodies, and antineutrophil cytoplasmic antibodies are not seen.

Diagnosis and Clinical Course

The diagnosis of BS is based on the recognition of a group of clinical features because no specific signs or symptoms have been identified. In 1990, the International Study Group published a set of diagnostic (classification) criteria.6 These criteria, with a sensitivity of 91% and specificity of 96%, have been validated and are widely used (see Table 1, above right).

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:Behçet’s diseaseDiagnostic CriteriaPathogenesisTreatment

Related Articles

    Case Report: An Unusual Presentation of Neuro-Behçet’s Disease

    April 15, 2022

    A 44-year-old woman presented to the emergency department with bifrontal headaches that had started approximately one month earlier. She was diagnosed with migraines and discharged home. Three days later, the patient returned to the emergency department upon recurrence of her headaches, and this time she also reported abnormal leg movements. A computerized tomography (CT) scan…

    Case Report: A Behçet’s Patient Develops Cerebral Venous Sinus Thrombi

    December 17, 2018

    A 39-year-old woman presented at the emergency department with three weeks of progressive, constant and pulsatile right-sided headache. She said her headache was worse in the morning and when she would bend forward. She reported associated nausea and vomiting. On initial assessment, she did not have any focal neurological deficits. Her medical history was significant for…

    Case Report: Which Vasculitis Is It?

    June 15, 2020

    A 13-year-old, adopted girl of unknown ancestry with social anxiety, selective mutism and Takayasu arteritis presented for evaluation of severe, painful, gingival hyperplasia, which limited her oral intake and resulted in weight loss. The young patient was diagnosed with Takayasu arteritis at age 8, when she presented with a persistently elevated erythrocyte sedimentation rate (ESR),…

    Ustekinumab for Behçet’s Disease? The Study Results Are In

    June 15, 2020

    In a multicenter, prospective, open-label study, ustekinumab therapy was effective in treating oral ulcers resistant to colchicine in patients with Behçet’s disease, according to study author David Saadoun, MD, PhD, Department of Internal Medicine and Clinical Immunology, Sorbonne University, Paris, and fellow researchers.1 Researchers focused on the topic because oral ulcers are often disabling, have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences